- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
GRI Bio Inc (GRI)
GRI Bio Inc stock price live, this page displays NASDAQ GRI stock exchange data. View the GRI premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the GRI Bio Inc real time stock price chart below.
What Is the GRI Bio Inc Stock Price Today?
The GRI Bio Inc stock price today is 2.000.
What Is the Stock Symbol for GRI Bio Inc?
The stock symbol for GRI Bio Inc is "GRI."
What Stock Exchange Does GRI Bio Inc Trade On?
GRI Bio Inc is listed and trades on the NASDAQ stock exchange.
Is GRI Bio Inc a Good Stock to Buy?
Determining whether GRI Bio Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the GRI quote. (ISIN: US3622AW5029)
What Is the GRI Bio Inc Stock Price Today?
The GRI Bio Inc stock price today is 2.000.
What Is the Stock Symbol for GRI Bio Inc?
The stock symbol for GRI Bio Inc is "GRI."
What Stock Exchange Does GRI Bio Inc Trade On?
GRI Bio Inc is listed and trades on the NASDAQ stock exchange.
Is GRI Bio Inc a Good Stock to Buy?
Determining whether GRI Bio Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the GRI quote. (ISIN: US3622AW5029)
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1.870
2.020
52 wk Range
1.360
80.360
GRI is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1.8702.020
52 wk Range
1.36080.360
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
GRI Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Strong Buy
Price Target
18.500
Upside
+825.00%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Quickly burning through cash
Form 8K GRI Bio Inc For: 14 May- Investing.com
Form 8K GRI Bio Inc For: 18 June- Investing.com
- Form 8K GRI Bio Inc For: 18 June
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy
Analyst Ratings
2 Buy
0 Hold
0 Sell
Ratings:
2 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 18.500
(+825.00% Upside)
Earnings
Latest Release
Aug 19, 2026
EPS / Forecast
-0.91 / -1.35
Revenue / Forecast
-- / --
Compare GRI to Peers and Sector
Metrics to compare | GRI | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipGRIPeersSector | |
|---|---|---|---|---|
P/E Ratio | −0.5x | −2.1x | −0.4x | |
PEG Ratio | 0.00 | 0.10 | 0.00 | |
Price/Book | 0.4x | 5.3x | 2.6x | |
Price / LTM Sales | - | 42.8x | 3.1x | |
Upside (Analyst Target) | - | 209.9% | 49.0% | |
Fair Value Upside | Unlock | 15.6% | 7.1% | Unlock |
GRI Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing therapies that target diseases leading to inflammatory, fibrotic, and autoimmune disorders in the United States. Its lead product candidate is GRI-0621, an oral inhibitor of type 1 Natural Killer T cells, which is in phase IIa clinical trial for the treatment of severe fibrotic lung diseases, such as idiopathic pulmonary fibrosis. The company’s portfolio also includes GRI-0803, a novel oral agonist of type 2 Natural Killer T cells that is in preclinical development for the treatment of autoimmune disorders; a proprietary library of 500+ compounds; and GRI-0124 and GRI-0729 for balance inflammatory immune responses. The company was formerly known as Glycoregimmune, Inc. GRI Bio, Inc. was founded in 2009 and is based in LA Jolla, California.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the GRI Bio (GRI) Stock Price Today?
The GRI Bio stock price today is 2.000 USD.
What Stock Exchange Does GRI Bio Trade On?
GRI Bio is listed and trades on the Nasdaq Stock Exchange.
What Is the Stock Symbol for GRI Bio?
The stock symbol for GRI Bio is "GRI."
What Is the GRI Bio Market Cap?
As of today, GRI Bio market cap is 4.370M USD.
What Is GRI Bio's Earnings Per Share (TTM)?
The GRI Bio EPS (TTM) is -11.554.
When Is the Next GRI Bio Earnings Date?
GRI Bio will release its next earnings report on Nov 18, 2026.
From a Technical Analysis Perspective, Is GRI a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has GRI Bio Stock Split?
GRI Bio has split 5 times.
What is the current trading status of GRI Bio (GRI)?
As of Sep 03, 2026, GRI Bio (GRI) is trading at a price of 2.000 USD, with a previous close of 1.910 USD. The stock has fluctuated within a day range of 1.870 USD to 2.020 USD, while its 52-week range spans from 1.360 USD to 80.360 USD.
What Is GRI Bio (GRI) Price Target According to Analysts?
The average 12-month price target for GRI Bio is 18.500 USD, with a high estimate of 27 USD and a low estimate of 10 USD. 2 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +825.00% Upside potential.
What Is the GRI Premarket Price?
GRI's last pre-market stock price is 2.000 USD. The pre-market share volume is 1,770.000, and the stock has decreased by 0.090, or 4.710%.
What Is the GRI After Hours Price?
GRI's last after hours stock price is 1.970 USD, the stock has decreased by -0.030, or -1.500%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.